Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin
- PMID: 1657924
Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin
Abstract
In order to investigate the mechanism of topoisomerase I inhibition by camptothecin, we studied the induction of DNA cleavage by purified mammalian DNA topoisomerase I in a series of oligonucleotides and analyzed the DNA sequence locations of preferred cleavage sites in the SV40 genome. The oligonucleotides were derived from the sequence of the major camptothecin-induced cleavage site in SV40 DNA (Jaxel, C., Kohn, K. W., and Pommier, Y. (1988) Nucleic Acids Res. 16, 11157 to 11170) with the cleaved bond in their center. DNA length was critical since cleavage was detectable only in 30 and 20 base pair-(bp) oligonucleotides, but not in a 12-bp oligonucleotide. Cleavage was at the same position in the oligonucleotides as in SV40 DNA. Its intensity was greater in the 30- than in the 20-bp oligonucleotide, indicating that sequences more than 10 bp away from the cleavage site may influence intensity. Camptothecin-induced DNA cleavage required duplex DNA since none of the single-stranded oligonucleotides were cleaved. Analysis of base preferences around topoisomerase I cleavage sites in SV40 DNA indicated that camptothecin stabilized topoisomerase I preferentially at sites having a G immediately 3' to the cleaved bond. Experiments with 30-bp oligonucleotides showed that camptothecin produced most intense cleavage in a complementary duplex having a G immediately 3' to the cleavage site. Weaker cleavage was observed in a complementary duplex in which the 3'G was replaced with a T. The identity of the 3' base, however, did not affect topoisomerase I-induced DNA cleavage in the absence of drug. These results indicate that camptothecin traps preferentially a subset of the enzyme cleavage sites, those having a G immediately 3' to the cleaved bond. This strong preference suggests that camptothecin binds reversibly to the DNA at topoisomerase I cleavage sites, in analogy to a model previously proposed for inhibitors of topoisomerase II (Capranico, G., Kohn, K.W., and Pommier, Y. (1990) Nucleic Acids Res. 18, 6611-6619).
Similar articles
-
Oligonucleotide-Recognizing Topoisomerase Inhibitors (OTIs): Precision Gene Editors for Neurodegenerative Diseases?Int J Mol Sci. 2022 Sep 29;23(19):11541. doi: 10.3390/ijms231911541. Int J Mol Sci. 2022. PMID: 36232843 Free PMC article. Review.
-
Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin.Nucleic Acids Res. 1993 Nov 11;21(22):5157-66. doi: 10.1093/nar/21.22.5157. Nucleic Acids Res. 1993. PMID: 8255771 Free PMC article.
-
Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.Nucleic Acids Res. 1988 Dec 9;16(23):11157-70. doi: 10.1093/nar/16.23.11157. Nucleic Acids Res. 1988. PMID: 2849758 Free PMC article.
-
Spatial organization of topoisomerase I-mediated DNA cleavage induced by camptothecin-oligonucleotide conjugates.Nucleic Acids Res. 2003 Jul 15;31(14):4031-40. doi: 10.1093/nar/gkg457. Nucleic Acids Res. 2003. PMID: 12853620 Free PMC article.
-
Camptothecins as probes of the microenvironments of topoisomerase I--DNA complexes.Ann N Y Acad Sci. 2000;922:76-91. doi: 10.1111/j.1749-6632.2000.tb07027.x. Ann N Y Acad Sci. 2000. PMID: 11193927 Review.
Cited by
-
Oligonucleotide-Recognizing Topoisomerase Inhibitors (OTIs): Precision Gene Editors for Neurodegenerative Diseases?Int J Mol Sci. 2022 Sep 29;23(19):11541. doi: 10.3390/ijms231911541. Int J Mol Sci. 2022. PMID: 36232843 Free PMC article. Review.
-
Tyrosyl-DNA Phosphodiesterase I N-Terminal Domain Modifications and Interactions Regulate Cellular Function.Genes (Basel). 2019 Nov 6;10(11):897. doi: 10.3390/genes10110897. Genes (Basel). 2019. PMID: 31698852 Free PMC article. Review.
-
Enhancement of camptothecin-induced topoisomerase I cleavage complexes by the acetaldehyde adduct N2-ethyl-2'-deoxyguanosine.Nucleic Acids Res. 2004 Oct 21;32(18):5685-92. doi: 10.1093/nar/gkh902. Print 2004. Nucleic Acids Res. 2004. PMID: 15498925 Free PMC article.
-
Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages.Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2040-5. doi: 10.1073/pnas.040397497. Proc Natl Acad Sci U S A. 2000. PMID: 10688881 Free PMC article.
-
Localization of an aminoacridine antitumor agent in a type II topoisomerase-DNA complex.Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11007-11. doi: 10.1073/pnas.91.23.11007. Proc Natl Acad Sci U S A. 1994. PMID: 7971998 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials